Checkpoint Therapeutics (CKPT ) Tops Q3 EPS by 46c

Checkpoint Therapeutics (NASDAQ: CKPT ) reported Q3 EPS of ($0.29), $0.46 better than the analyst estimate of ($0.75).

For earnings history and earnings-related data on Checkpoint Therapeutics (CKPT ) click here.

You May Also Be Interested In

• Macy's (M) Tops Q2 EPS by 28c, Beats on Revenue; Offers FY Guidance
• H.C. Wainwright Reiterates Buy Rating on Ascendis Pharma (ASND)
• William Blair Starts Clean Harbors (CLH) at Outperform, Adds to Conviction List, 'New Top Pick in Waste'